Faron Pharmaceuticals Oy Share Discussion Threads

[toffeeman] 01/5/2020 08:16

You wait until (if it ever does) hit the top 10 risers - then we will be invaded by numpties - just be grateful until you're not!

[ambyth] 01/5/2020 07:58

I'm in. Its very quiet here

[elliotset] 27/4/2020 06:48

Great news today

[hashertu] 23/4/2020 13:09

Good outcome from the placing.

[dan1nat1] 22/4/2020 20:59

Vaccine development!https://article-directory.org/article/747/53/Faron-Pharmaceuticals-current-progress-on-Covid-19-vaccine"Clevegen, its precision immunotherapy, is a novel anti-Clever-1 antibody with the capability to switch immune suppression to immune activation in different situations, with potential across oncology, infections disease and Covid-19 vaccine development."

[yep1234] 22/4/2020 08:16

FYIhttps://www.faron.com/sites/default/files/Latest%20investor%20presentation_22042020.pdf

[dan1nat1] 21/4/2020 21:15

I think things are moving very quick now we are on remap, the partner situation probably changed the instant we signed up...which wasn't very long ago.Final results maybe 2022, that doesn't mean we won't get updates along the way, and you can bet if Traumakine is as good as we hope that demand for a fast tracked P3 trial will be substantial.

[daffodil4] 21/4/2020 20:37

OK...but would you not have expected Markuu to
have discussed that possibility....Also
REMAP trial results are not expected till 2022
so it would be quicker to go the FDA route??

[dan1nat1] 21/4/2020 19:37

No I am assuming if we are successful in the Remap trial we will quickly move to £15+ and be quite capable of raising funds without the need for a partner.

[daffodil4] 21/4/2020 19:22

dan1nat1

From today's RNS..

" and seeks third party financing for Traumakine to allow
initiation of a US trial following the acceptance by the FDA
of the Company's protocol for a new US Truamakine trial "
So Faron clearly saying that to get FDA approval they need
to complete the trials Inegrity and Calibre...You are
assuming the REMAP trial would be an alternative way,
but Markuu would have confirmed that if it was a possibility
but he did not.......I did wonder if that might be a possibility
you will see if you look back on my earlier posts..but
after reading today's RNS it is clear that Faron are
still looking for a third party to fund the FDA trials..

[soulected] 21/4/2020 18:33

Did you actually read the whole RNS?

[dan1nat1] 21/4/2020 18:07

LOL...don't you realise we might not need a partner now we basically have the trial testing Traumakine being paid for by someone else. If you don't grasp that you really are in the wrong share.

[daffodil4] 21/4/2020 16:10

I disagree......This means that the Partner discussions
they have been saying would hopefully result in a deal
have come to nothing...Very disappointed ..they said
the last placement would see them to Q4 2020 and
we are only just in Q2....These will be flipped
and the price will fall to the placing price...

[davidlloyd] 21/4/2020 15:55

Suggests to me the intel has identified clear insti demand for these then.....
DL

[elliotset] 15/4/2020 10:14

Support around £2.50 if it breaks that then £1.50

[soulected] 15/4/2020 09:41

They are my thoughts, trying to engage the conversation on the more active LSE, but no one seems to want to discuss. The volume is so low, so in the same way it can't really be seen as bad news coming either...

[daffodil4] 15/4/2020 09:20

Thoughts on drop??
Is is because SNG seems the
more likely treatment for Covid-19
using Interferon beta ?
I see their trial has been labelled urgent
by National Institue for Halth Research.
No volume here, whereas all other
drugs/tests related to Convid-19
are flying....

[daffodil4] 04/4/2020 12:46

Surprised we did not end higher..
I think the fact that the results are
due 2022 has maybe have held this back..
Wonder if they will still do the
trials as planned or will this
be the way forward....and not
need partner funding ..??
Great update on Clevegen but
not reflected in share price .very surprised..
may drift till further news...GLA!

[jojaken] 02/4/2020 03:56

Hugely encouraged by yesterday’s announcement that Faron was included in the REMAP-CAP program. Looking at the details the US was the only major region excluded from the REMAP-CAP program. Interestingly, a leading article in the NYT was looking at how own immune systems is the new area of focus in the battle against Covid-19. From the article it would appear that Tocilizumab is seen as an alternative candidate in the US. Could this be the start of a two way tussle between two similar, but different therapies?

For now this can only be good, as Traumakine gains traction as a lead therapy outside the US. Interesting times indeed!

hxxps://www.nytimes.com/2020/04/01/health/coronavirus-cytokine-storm-immune-system.html?action=click&module=Top%20Stories&pgtype=Homepage

[hashertu] 01/4/2020 14:14

This is potentially a very significant development.
Effectively a fast tracked trial, I assume open label, with a steroid only comparator.
Let's hope for a good outcome for all involved.

[daffodil4] 01/4/2020 09:08

bwgs

My post was on 30th March about Clevegen update..
so with today's RNS I am really surprised this
is not well over £6....possibly MM's at play
fairly small float...let's see where we close!
Hopefully Markuu will do the PR rounds..GL.

[bwgs] 01/4/2020 08:32

So did I Daffodil, any positive on the back of this though should motor us upwards.Market generally in the red today which doesn't help matters either. Great opportunity for FARN now

[toffeeman] 01/4/2020 07:51

Here as well BMNSA - I have a small holding as well (via Guinness AIM EIS)